Index

---

• 6‐minute walk (6MW) performance 146
  • compromise 143

• acamprosate (Campral), usage 440
• acceptance and commitment therapy (ACT) 248
• accountable care organization (ACO), coordinated/colocated systems 287
• acetaminophen (paracetamol), usage 134
• acne 451, 452
• actigraphy, usage 462
• active mental model, areas 304
• activities of daily living (ADLs), disruption 98
• acupoints 251
• acupuncture 251–252, 429
  • efficacy 134
  • migraine headache usage 137
  • tobacco use cessation 230
• acute exercise, impact 409–410
• acute illness adjustment, chronic illness adjustment (contrast) 374
• acute stress, counteracting 357–358
• addictions, medical resident stigma‐related concerns 59
• adherence. See medication adherence; patient adherence
  • defining 375
• adolescence, development/health 332
• adolescents
  • adolescent‐focused therapy, family‐based treatment (comparison) 123–124
  • alcohol consumption (reduction), self‐affirmation implementation intention intervention (development) 49
  • alcohol use/abuse, longitudinal pathways (exploration) 312
  • anorexia nervosa, family therapy (usage) 123–124
  • CAM approaches 246
  • medication regimens, nonadherence 376
  • sexual orientation/gender minority, identification 419
  • stress responses 374
• adulthood, sexual trauma (negative health consequences) 154
• adults, depression screening (USPSTF recommendation) 197–198
• Adverse Childhood Experiences Study 154
• advertising (psychologists) 431–432
• aerobic exercises, participation (impact) 409
• affective forecasting 293
  • bias 295
  • difference variables, impact 295
  • errors 295
    • impact 297
  • focus 295
  • generalized affective forecasts, importance 298–299
  • health‐related examples 296
  • impact 297
    • study 294
  • quality, determination 299
  • research 295–296
  • role 296–297
• affective reactions, gender differences 23
• Affordable Care Act. See Patient Protection and Affordable Care Act
• Agency for Healthcare Research and Quality (AHRQ), CBT‐I efficacy review 463
• aging 301
• agoraphobia, panic (relationship) 455
• alcohol
  • abuse diagnosis, establishment 67–68
  • alcohol‐related birth defects/neurodevelopmental disorders 438
  • alcohol‐related diagnoses, classification (DSM change) 67
  • alcohol‐related Korsakoff's syndrome, results 437
  • alcohol‐related motor vehicle accidents, NHTSA estimates 70
  • alcohol‐related NCD 95
  • blood alcohol concentration (BAC), increase 69
  • hepatitis 438
  • reaction time/decision making impairment 70
• alcohol consumption
  • acute alcohol consumption, impact 69–70
  • acute effects 69–70
  • breast cancer risk, increase (relationship) 48
  • chronic alcohol consumption, impact 437
  • definitions 69
  • detrimental outcomes 438
  • excess, impact 437–438
  • moderation, health benefits 438
  • prediction 68–69
• Alcohol Dependence Scale (ADS) 238
• alcoholic liver disease, treatment 441
• Alcoholics Anonymous (AA), usage 440
• alcoholism 67
• alcohol use
  • avoidance 40
  • longitudinal pathways, exploration 312
  • long‐term negative health outcomes 437–438
  • social cognitive theories 68–69
• alcohol use disorder (AUD) 67
  • acamprosate (Campral), usage 440
  • Alcoholics Anonymous (AA), usage 440
  • behavioral couples therapy (BCT) 439–440
  • biopsychosocial framework, usage 68
  • cognitive behavioral (CB) approaches/interventions 439
  • development 68
  • disulfiram, usage 440
  • etiological influences 68–70
  • interventions 439
  • long‐term consequences 437
  • maintenance 68
  • medical interventions 440–441
  • motivational interviewing (MI), usage 439
  • naltrexone (ReVia/Vivitrol), usage 440
  • onset 68
  • pharmacotherapy 440
  • prevalence 68
  • psychological factors, integration 68–69
  • relapse processes 68
  • support groups 440
  • treatment approaches 439–441
  • withdrawal symptoms, severity (decrease) 440–441
• allostatic load, manifestation 156
• allostatic mediators, production/dissemination 156
• alopecia 451
• alternative health techniques, ethics issues 427
• American Association of Retired Persons (AARP), family caregiver report 9
• American Board of Professional Psychology (ABPP), certification 347, 360
• American College of Cardiology Foundation, CAC report 84
• American Congress of Obstetricians and Gynecologists (ACOG), Committee on Obstetric Practice (depression screening recommendation) 197
• American Heart Association
  • Strategic Impact Goal 90
  • Task Force on Practice Guidelines, CAC report 84
• American Medical Association (AMA), Code of Ethics 289
• American Music Therapy Association, music therapy practitioner certification 253
• American Psychological Association (APA)
  • Ethics Code 428, 431
    • Standard 5.05 432
  • “Guidelines for Psychological Practices in Health Care Delivery Systems” 345
  • mission statement, amendment 355
  • Practice Guidelines 124
  • Prevention Guidelines 37
• American Psychosomatic Society, mission 357
• American Sexual Health Association (ASHA), oral contraceptive effectiveness data 387
• Americans with Disabilities Act (ADA) 60
  • passage 273
• anabolic‐androgenic steroid use, impact 412, 422
• anhedonia 87, 163–164
  • schizophrenia, relationship 164
  • self‐reported anhedonia, emotion regulation deficits (impact) 164
• anorexia nervosa (AN) 4, 117, 396
  • bone mass issues, association 121
  • family therapy 123–124
  • Maudsley model of AN treatment for adults (MANTRA) 123
  • psychotherapy, usage 122–124
  • reproductive consequences, association 121
  • specialist supportive clinical management (SSCM) 123
  • treatment, APA Practice Guidelines 124
  • weight restoration 123
• antiretroviral (ARV) medications 387
  • adherence, enhancement 387
• anxiety
  • aromatherapy, usage 249
  • disorders
    • medical disorders, comorbidity 237
    • primary care health settings screening 237
    • rates, elevation 122
  • health anxiety 452, 453–454
  • levels, increase 335
  • pediatric cancer, relationship 336
  • physical manifestations, reduction 368
  • physician screening (ACOG recommendations) 197–198
  • prevention/addressing 98
  • reduction 454
    • physical activity, impact 408
  • sensitivity 87
  • skin disease, relationship 451
  • SSRIs/SNRIs, usage 134
  • treatment, biofeedback (usage) 252
• Appearance Schemas Inventory 446
• appetite, change 193
• aromatherapy, usage 247, 249
• arrhythmias, bulimia nervosa (association) 121
• art therapy, usage 246
• Ashtanga yoga 250
• assent, implication 349
• assisted reproductive technology (ART), usage 28
• asthma 327
• athleticism, impact 412
• attentional resources, regulation 14
• attention deficit hyperactivity disorder (ADHD) 236
  • biofeedback, usage 252–253
  • medication, pilot usage 350
• attention, sustaining 60
• attention training 276
• autism spectrum disorders 236
• autonomic nervous system (ANS), activation 75
• autonomy supportive characteristic (MI) 267
• avolition 164–165
• Ayurveda 245, 246

• back pain (treatment)
  • acupuncture, usage 252
  • chiropractic, usage 248
• bacterial vaginosis (BV) 385
• bariatric surgery, usage 177–178
• Beck Anxiety Inventory (BAI) 237, 239
• Beck Depression Inventory (BDI) 208, 239
• Beck Depression Inventory for Primary Care (BDI‐PC) 237
• Beck Depression Inventory, Second Edition (BDI‐II) 237
• behavior
  • change, transtheoretical model 39–40
  • proximate/ultimate explanations 323
  • psychological mechanisms/processes, knowledge 324–325
• behavioral activation, impact 102
• behavioral adjustment 238
• behavioral care 13
• behavioral couples therapy for AUD (ABCT) 439–440
• behavioral health, behavioral medicine (contrast) 358
• behavioral health providers (BHPs)
  • administrative issues, types 284
  • appointment structure 285–286
  • billing/reimbursement 287–288
  • colleagues, interaction 289
  • confidentiality, management 288
  • documentation 286
  • general clinic supports 285
  • general practice, organization 284–285
  • integration, management considerations 284–286
  • multiple relationships, management 288–290
  • non‐colleague patients, interaction 289–290
  • office/clinic space 285
  • primary care integration 283
  • referral management 286–287
• behavioral medicine 358
• behavioral medicine, trends 311
  • biological issues 314–315
  • chronic diseases 312–313
  • chronic psychopathology, health problems/diseases (comorbidity) 316
  • diversity/inclusiveness 313–314
  • healthy psychology knowledge, translation 315
  • methodological sophistication 311–312
  • social justice 316–317
• behavioral regimens, adherence 217
• behavioral theories 39
• behavioral therapy (tobacco use disorder) 228–229
• Beliefs about Appearance Scale 446
• benefit finding (BF) 11
• Benson, Herbert 357
• benzodiazepines, effectiveness 440
• bereavement, impact 388
• Best Practices in Psychology 36
• Bikram yoga 250
• biliopancreatic diversion, duodenal switch (usage) 178
• binge drinking (SAMHSA definition) 69
• binge eating disorder (BED) 4, 118, 396
  • health complications, association 121
• binge eating, health risk behaviors 155
• biofeedback, usage 137, 252–253
• biologically based practices 247
• biological measures, examples 314–315
• biomedical reductionism 184
• biopsychosocial (BPS) approach 184
  • evolution 321–323
• biopsychosocial (BPS) functioning 322
• biopsychosocial (BPS) model 147, 184–185, 321, 355
  • focus 185
• biopsychosocial (BPS) perspective (suicide) 204–205
• biopsychosocial (BPS) perspectives 323–325
• biopsychosocial (BPS) practice (health psychology) 321
• biopsychosocial (BPS) term, usage 323
• biphobia, behaviors 418
• birth defects 30
• blood alcohol concentration (BAC), increase 69
• body
  • body‐based practices 247
  • dissatisfaction, risk factor 400
  • fat/muscularity, dimensions (satisfaction) 446
  • satisfaction/acceptance 409
• Body Checking Questionnaire 446
• body image 1
  • assessment 445
    • methodology 445–446
  • changes 447
  • clinical health psychology, relationship 2
  • concerns
    • correlates/consequences 3–5
    • risk factors 2–3
  • demographic/sociocultural/psychosocial variables, study 2–3
  • disorder/dissatisfaction 396
  • eating‐related behaviors 4
  • health behaviors 4
  • manifestation 2
  • measures, content/specificity (range) 446
  • mental health problems 3
  • populations, assessment 446–447
  • psychiatric conditions 4
  • psychological functioning, problems 3
  • sexual health, relationship 4–5
  • sport/exercise, relationship 409
  • weight‐related behaviors 4
• Body Image Avoidance Questionnaire 446
• body mass index (BMI)
  • levels 171
  • obesity definition 172
  • premature death/disability, association 172
  • quality of life, reduction 172
• Body Parts Satisfaction Scale 446
• Body Shape Questionnaire 446
• bone mass issues, anorexia nervosa (association) 121
• boundaries, rules/structures 430–431
• bradycardia, bulimia nervosa (association) 121
• brain
  • activity, suppression 135
  • schizophrenia 161
• breast cancer
  • diagnosis, psychological adjustment (trajectories) 77
  • patients, behavioral activation (impact) 102
• bright light therapy, usage 102
• Bronfenbrenner, Urie 327
• bulimia nervosa (BN) 4, 117–118, 396
  • cardiovascular issues, association 121
  • dialectical behavior therapy (DBT), usage 125
  • psychotherapy, usage 124–125
  • treatment, CBT (superiority) 124
• bullying, persistence 421
• bupropion, usage 176
• burnout, prevention 42

• cancer
  • cancer‐specific coping processes, psychological adjustment predictors 78
  • childhood cancer 335
  • chronic alcohol misuse, link 438
  • death rates, contributors 73
  • depressed cancer patients, treatment options (evaluation) 102
  • depression, association 101–103, 236
  • development, personality type impact (belief) 74–75
  • diagnosis, psychosocial aspects (improvement) 102
  • early detection, screening 75–76
  • early‐stage breast cancer, group therapy (impact) 101–102
  • existence, negative effect 295–296
  • experience, characterization 77
  • impact, studies 102–103
  • initiation/progression, behavioral/psychosocial factors 74–75
  • initiation, risk (reduction) 74
  • long‐term survivorship 76
  • mental health, deterioration 77
  • mortality, decline 73
  • outcomes, improvement 74
  • pediatric cancer 335–340
  • psycho‐oncology, relationship 73
  • psychosocial adjustment 76–77
    • demographic risk factors 78
    • predictors 77–78
  • recurrence, fear 241
  • reentry phase 76–77
  • screening
    • barriers, contextual/individual factors 75
    • individual‐level factors 76
    • USPSTF recommendations 75
  • survivorship periods 240
  • trajectory, adjustment 76–77
• Cancer by the Carton (Reader's Digest) 224
• capacity, implication 349
• cardiac disease, Framingham Risk Equation 85
• cardiac events
  • Framingham Risk Equation 85
  • reduction 90
• cardiology, primary care setting 239
• cardiovascular disease 327
  • mortality (reduction), Strategic Impact Goal (AHA) 90
• cardiovascular issues, bulimia nervosa (association) 121
• caregivers
  • assistance, technological forms 12
  • burden 10
  • caregiver‐focused, problem‐solving training 13
  • caregiver‐oriented interventions 276
  • caregiving class, coping 13
  • clinical health psychology, relationship 9
  • dementia caregivers, burden/depression (alleviation) 13–14
  • duties, break 12
  • enhanced care 13
  • enhanced support group 13
  • environmental skill building program 13
  • female caregivers, financial burden 10
  • information/referral, usage 13
  • interventions 13, 375
  • meditative‐based interventions 13–14
  • negative psychosocial sequelae 11
  • positive psychosocial sequelae 11–12
  • post‐caregiving 14–15
  • problem‐solving skills training (PSST) 375
  • psychosocial interventions 13–14
    • utilization, barriers 14
  • PTG, patient‐related factors (relationship) 11
  • respite 12
  • stressors, responses 13
  • support 12
• care‐recipient‐focused behavior management skill training 13
• cellulitis 451
• Centers for Epidemiologic Studies—Depression (CES‐D) scale 88–89, 89
• central nervous system (CNS), demyelinating disease 143
• cervix, narrowing 28
• change
  • fear 277
  • patient language 266
  • resistance, problem 266
  • talk 266, 267
• changes, self‐affirmation (impact) 52–53
• Chantix (varenicline tartrate) 228
• childhood
  • cancer 335
  • obesity, public health problem 373
  • sexual behaviors 391
• children
  • adolescence, development/health 332
  • anxiety, at‐risk range 336
  • asthma, suffering 373
  • CAM approaches 246
  • chronic illnesses, interventions (development) 373
  • community‐based programs, care 377
  • coping strategies (reduction), interventions (impact) 374–375
  • culture, impact 330
  • depression levels, increase 336
  • discrimination 331
  • early childhood, attachment security (importance) 332
  • ethnic minorities, healthcare (relationship) 329–331
  • exosystem 328
  • health 327
    • disparities 331
    • impact 328
  • healthcare access, disparities 330–331
  • hemoglobin A1c levels (reduction), telemedicine (impact) 377
  • language, disparities 331
  • macrosystem 328
  • maltreatment 327
  • medication adherence 337–339, 375–376
    • barriers 375–376
  • mesosystem 327–328
  • microsystem 327–328
  • middle childhood, developmental milestones 332
  • negative health status, impact 328
  • outcomes, perinatal depression development timing (impact) 196
  • pediatric cancer 335–340
  • poverty, long‐term impact 329
  • protective/risk factors 331–332
  • sexual attraction (pedophilic disorder) 390
  • sociodemographic disadvantage 337
  • socioeconomic status (SES), impact 329
  • stress reduction, interventions (development) 374–375
  • stress responses 374
• chiropractic therapy, usage 133
• chiropractic, usage 247, 248–249, 429
• chlamydia 385
  • infections, reduction 386
• chronic alcohol consumption, impact 437
• chronic alcohol misuse, link 438
• chronic disease
  • long‐term alcohol consumption, impact 437
  • management, preference‐sensitive decisions 297
  • physical/psychological symptoms 147
  • psychosocial variables, emphasis 312–313
• chronic health problems/diseases, biological factors 314–315
• chronic illnesses
  • adjustment, acute illness adjustment (contrast) 374
  • treatment, advances 374
• chronic physical health problems, depression management 369–370
• chronic physical illness, impact 365
• chronic psychopathology, health problems/diseases (comorbidity) 316–317
• chronic stress
  • body system, burden 156
  • counteracting 357–358
• chronic stressors 418–419
• chronic tension‐type headache (CTTH) 131
  • acupuncture, efficacy 134
  • pain threshold, reduction 132
  • SSRIs/SNRIs, usage 134
• cigarette smoking, impact 87
• clinical competence (psychologists) 428–429
• clinical health psychology
  • ABPP recognition 359
  • APA Division of Health Psychology definition 356
  • application/focus 355–356
  • body image, relationship 2
  • caregivers, relationship 9
  • competencies 359–360
  • education/training 359–361
  • future 361
  • history 355
  • problem areas, psychologist examination 356
  • professional organizations, formation 357–361
  • specialization 360
• Clinical Health Psychology Specialty Taxonomy, CCHPTP development 360
• clinical health psychology, trends 311
  • biological issues 314–315
  • chronic diseases 312–313
  • chronic psychopathology, health problems/diseases (comorbidity) 316
  • diversity/inclusiveness 313–314
  • health psychology knowledge, translation 315
  • methodological sophistication 311–312
  • social justice 316–317
• clinical hypnosis 257–258
• close relationships 19
• cluster headaches 138
• coaches, transformational leadership qualities 411
• Cochrane Reviews 245, 260
• Code of Ethics (AMA) 289
• cognition, social problem solving/work skills (association) 162
• cognitive behavioral therapy (CBT) 112, 198
  • benefits 109
  • efficacy 133
  • interventions 29
  • superiority 124
  • third‐wave CBT 125
  • usage 123
• cognitive behavioral therapy for insomnia (CBT‐I) 462–463
  • AHRQ efficacy review 463
• cognitive behavior therapy (CBT) 370
  • adherence, improvement 315
• cognitive decline, impact 98
• cognitive deficits 162–163
• cognitive expectancies 68
• Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) 163
• cognitive processing, types 324–325
• cognitive remediation (DR) 163
• cognitive therapy (CG) 462
  • benefits 109
  • mindfulness version 109
• Cognitive Therapy for Suicide Prevention (The Joint Commission) 211
• Collaborative Assessment and Management of Suicide (The Joint Commission) 211
• commonsense model of self‐regulation (CSM)
  • construct 305
  • framework 303–304
• Community Integration Questionnaire (CIQ) 238–239
• community, promotion 38
• comorbid depression, impact 87–88
• comorbidities
  • depressive comorbidity, studies 102
  • detection/management 97
  • eating disorders 121–122
  • health context 101
  • insomnia 460–461
  • perinatal depression 197
  • psychiatric comorbidity 227
• complementary and alternative medicine (CAM) 199, 245, 427
  • approaches (children/adolescents) 246
  • boundaries, rules/structures 430–431
  • domains, NCCIH perspective 246–247
  • integration 433–434
  • modalities
    • efficacy (NCCIH information) 245–246
    • integration 430–431
    • psychologist knowledge, necessity 429
    • usage, benefits 429
  • presence (US) 246
  • prevalence 428
  • services, offering 432
• complementary and alternative treatments 245
  • tobacco use disorder 229–231
• complementary health techniques, ethics issues 427
• complicated grief, occurrence 31
• condom use practices, increase 386
• confidentiality
  • APA standards 288
  • limits, controls 348
  • psychologist confidentiality 348
• confusion, increase 97
  • dehydration, impact 97
• conscientiousness 37
• consent, implication 349
• Consortium on the Genetics of Schizophrenia (COGS) 163
• constipation, prevention 97
• contraceptive methods 387–388
• co‐occurring disease‐related stigmas, concern 62
• coping
  • behaviors 410
  • concept, utility (question) 421
  • mechanisms, taxing 418–419
  • skills 204, 238
  • strategies (reduction), interventions (development) 374–375
• coronary artery calcification (CAC)
  • depression, relationship 86, 88–90
  • lower‐risk/higher‐risk, odds ratios 89
  • persistent/recurrent depression prediction ability 86
  • prevalence/progression, smoking (dose‐dependent predictor) 87
  • progression limitation/development prevention 90
  • smoking, relationship 88–90
  • subclinical measure 84
  • Whitehall II study 86
• Coronary Artery Risk Development in Young Adults (CARDIA) study 88
• coronary heart disease (CHD), prevalence 239
• Council of Clinical Health Psychology Training Programs (CCHPTP), Clinical Health Psychology Specialty Taxonomy development 360
• couples, serious/chronic illnesses 20
• Craig Handicap Assessment and Reporting Technique (CHART) 238–239
• cramping (miscarriage symptom) 30
• CREATE randomized controlled trials 313
• cross‐dressing, sexual arousal 390
• culture
  • impact 330
  • medical culture, psychologists (interactions) 345–346
• Current Procedural Terminology (CPT) codes, usage 287–288
• cystic fibrosis (CF)
  • psychologist treatment 352
  • services 350

• daily caloric intake, goal setting 174
• daily sleep diaries, usage 461–462
• dance movement therapy (DMT) 246, 247, 251
• death
  • causes
    • biopsychosocial (BPS) perspective 323–325
    • ranking 324
  • risk (reduction), suicide (impact) 208
  • thoughts 193
• decisional bias (mitigation), disability paradox/affective forecasting errors (impact) 297
• decision making
  • affective forecasts, impact (study) 294
  • processes, alcohol‐related expectancies (interaction) 58
• delayed ejaculation 388
• delirium
  • benzodiazepines, usage (effectiveness) 440
  • recognition/management 98
• dementia caregivers, burden/depression (alleviation) 13–14
• dementia, recognition/management 98
• depressed smokers, treatment 103
• depression 83
  • cancer, association 101–103
  • chronic health problems, assessment/follow‐up 112
  • chronicity, longitudinal effect (modeling attempt) 86
  • comorbid depression, impact 87–88
  • concepts, combination 108
  • coping skills, education 111
  • coronary artery calcification, relationship 86, 88–90
  • definition 107–108
  • depression‐smoking comorbidity, recognition/treatment 90
  • evidence‐based therapies 112–113
  • health context 101, 107
  • impacts, prediction 84–85
  • interpersonal psychotherapy (IPT), usage 108–109
  • ischemic heart disease (relationship), smoking (role) 87–90
  • levels, increase 335
  • management (older adults) 369–370
  • mechanisms, impact (hypothesis) 85
  • mothers, pregnancy (depression) 194
  • negative effects 84–86
  • nonclinical depression, reduction 408–409
  • patient social network, evaluation/intervention 112
  • pediatric cancer, relationship 336
  • perinatal depression 193
  • prevalence 107–108
  • prevention/addressing 98
  • psychological manifestations 144
  • psychosocial variables, behavioral activation (usage) 102
  • relapse, relationship 1097
  • risk, medical illnesses (association) 236
  • screening 236–237
    • value, potential 237
  • smoking, comorbidity 87
  • subtypes, differential associations 89–90
  • term, usage 193
  • tobacco smoking/ischemic heart disease, relationship 88
  • tobacco smoking, relationship 83–84
  • treatment
    • acupuncture, usage 252
    • acute phase, IPT interventions 109
    • effects 111
    • SSRIs/SNRIs, usage 134
  • walking
    • bidirectional association 144–145
    • relationship 143
  • Whitehall II study 86
• depression, relapse prevention
  • enhancement 110
  • mindfulness‐based therapy, potential 109
  • research, growth 111
  • strategies 111–113
    • patient treatment preferences, consideration 113–114
  • studies 108–109
• depressive comorbidity
  • challenge, consideration 104
  • diversity, relationship 103–104
  • studies 102
• depressive disorders risk (increase), multi‐morbidity (impact) 366
• depressive relapse
  • chronic health problems, assessment/follow‐up 112
  • examples 109–110
  • research 110
• depressive symptomatology, clusters (differential associations) 89–90
• depressive symptomotology
  • risk 148
  • walking impairment, cyclical associations 144
• depressive symptoms
  • behavioral approaches 148
  • chronic exposure/accumulation, impact 86
  • clinical elevation 88–89
  • disordered eating symptoms, association 122
  • dysphoria, change (synergistic effect) 103
  • psychological manifestations 144
  • severe clinical depression, clarifications/distinctions 111
  • walking (bidirectional, cyclical association) 145–146
  • walking impairment, association
    • longitudinal associations, tested model 147
    • possibility 145
    • studies 146–147
  • walking impairment changes, impact 148
• diabetes
  • depression, association 236
  • pharmacotherapy, immigrant status (associations) 314
• diabetes mellitus, development (likelihood) 438
• Diabetes Prevention Program (DPP) lifestyle treatment effects demonstration 175
• Diagnostic Interview with Structures Hamilton (DISH) 239
• dialectical behavior therapy (DBT), usage 125, 248
• Diamond, David/Martha 29
• did not keep (DNK) appointments, allowance 346
• dietary supplements, usage 247
• dieting, risk factor 400
• difference variables, impact 295
• dilation and curettage (D&C) 30
• disability
  • increase (older adults) 367
  • obesity, association 172
  • paradox 293–294
    • errors, impact 297
    • findings/studies 294
  • person‐first perspective 275–276
• disabled elderly, care 42
• discrepancy, development (MI principle) 41
• discrimination, promotion 418
• disease
  • causes, biopsychosocial (BPS) perspective 323–325
  • proximate/ultimate explanations 324
  • stigma 57
    • components 57
• distress tolerance 87
• disulfiram, usage 440
• diversity, depressive comorbidity (relationship) 103–104
• donor sperm, usage 28–29
• Drinker's Check‐up 265
• drinking
  • motives 68
  • refusal self‐efficacy 68
• Drive for Muscularity Scale 447
• Drug Abuse Screening Test (DAST‐20) 238
• Dunbar, Flanders 357
• duodenal switch, usage 178
• dynamic psychological processes, data 165–166
• dysphoria
  • change, synergistic effect 103
  • gender dysphoria 351–352
• dysregulated stress reactions 155–156

• early childhood, attachment security (importance) 332
• early‐onset Alzheimer's disease 95
• early‐stage breast cancer, group therapy (impact) 101–102
• eating
  • behaviors, risk/disorder (approach) 396
  • eating‐related behaviors, body image (relationship) 4
  • health psychology 395
  • problems, student assessment/support (Tier 3) 401–402
• Eating Disorder Examination 445
• eating disorders (EDs) 117, 118
  • acculturation levels/acculturative stress, impact 120–121
  • anxiety disorder rates, elevation 122
  • behavior, risk (reduction) 400
  • biological factors 119
  • comorbidity 121–122
  • complications 121
  • cultural risk factors 119–120
  • defining, method 118
  • diversity considerations 120–121
  • gender differences 120
  • genetic risk factors 119
  • medical management 125
  • monoamine oxidase inhibitors (MAOIs), usage 125
  • mortality rate, elevation 121
  • nutritional therapy 125
  • partial hospitalization 126
  • perfectionistic tendencies 119–120
  • prevention intervention, design/study 401
  • prognosis 126
  • psychological factors 119–120
  • psychotherapy, usage 122–125
  • residential treatment 126
  • risk factors 119–121
  • selective serotonin reuptake inhibitors (SSRIs), usage 125
  • self‐monitoring 124
  • sexual orientation, correlation 121
  • social factors 119–120
  • substance use disorders, commonness 122
  • subthreshold levels 118–119
  • symptoms, athleticism/exercise (impact) 412
  • treatment 122–126
    • PHP option 126
  • tricyclic antidepressants (TCAs) 125
  • types 117–119
• e‐cigarettes, components 224
• ecological framework, children (negative health status) 328
• ecological model (Bronfenbrenner) 323
• ecological momentary assessment (EMA) 165–166
• eczema 451, 452
• Edinburgh Postnatal Depression Scale (EPDS) 198
• education, prevention model framework 398
• effort
  • construct, complexity 165
  • deficits 164–165
  • effort‐based performance deficits, pattern 165
• ego depletion 157
• elderly (depression management), pharmacotherapy/psychotherapy (efficacy) 369
• electroencephalography (EEG), usage 46–47
• electromagnetic therapy 247
• electronic health record (EHR)
  • impact 348
  • systems, usage 284, 287
• electronic nicotine delivery systems (ENDS), marketing 223
• emotion
  • abnormalities 163–164
  • paradox 164
  • regulation 399
    • deficits, impact 164
• emotional intelligence, score (elevation) 295
• emotional management 295
• emotional pain, distance 157
• emotional responses, strategic/intentional withholding 157
• emotional states, duration/intensity (overestimation) 294–295
• emotional stress, prevention 42
• emotional well‐being, role 297–298
• empathy, expression (MI principle) 41
• Energy Expenditures for Rewards Task (EEfRT) 165
• energy therapies 247
• engaging (MI process) 268
• enhanced care 13
• Enhancing Recovery in Coronary Heart Disease (ENRICHD) randomized controlled trials 313
• environmental skill building program 13
• epidemiological transition 323–324
• epilepsy, alcohol consumption (impact) 437–438
• episodic memory, delay 14
• episodic tension‐type headache (ETTH) 131
  • acupuncture, efficacy 134
• erection, obtaining (difficulty) 388
• error‐related negativity (ERN) response, examination 46–47
• Ethical Code (APA) 288–289
• “Ethical Principles of Psychologists and Code of Conduct” (APA) 289
• Ethics Code (APA) 428, 431
  • Standard 5.05 432
• ethnic minorities, healthcare (relationship) 329–331
• European Organization for Research and Treatment of Cancer (EORTC), quality of life questionnaire (QLC‐C30) 241
• evoking (MI process) 268
• exercise
  • acute exercise, impact 409–410
  • aerobic exercises, participation (impact) 409
  • behavior, self‐affirmation/implementation intention combination (impact) 49
  • cause 407–410
  • concurrent factors 411–413
  • effect 410–411
  • health psychology context 407
  • high‐intensity exercise, impact 408–409
  • impact 412
  • injury 410
  • positive health outcomes 412
• exhibitionistic disorder 390
• exosystem 328
• Expanded Disability Status Scale (EDSS) 143
• Expectancy that Actions Produce Immediate Outcomes (EAPIO) 304

• falling, fear (older adults) 368–369
• fallopian tubes, blockage 28
• falsifiable hypotheses, experimental tests (findings replication) 322
• families
  • adjustment, pediatric cancer diagnosis 337
  • care partners, health (promotion) 98–99
  • children, health (impact) 328
  • ethnic minorities, healthcare (relationship) 329–331
  • family‐based structural multisystem in‐home intervention 13
  • health 327
  • social support, exerciser perceptions 411
• family‐based treatment (FBT), adolescent‐focused therapy (comparison) 123–124
• Family Caregiver Alliance, national registry (usage) 12
• fatigue
  • experience 193
  • management (older adults) 367
• fats, human craving 324
• feeding disorders 118
• female caregivers, financial burden 10
• fetal alcohol syndrome (FAS) 438
• fetishistic disorder 390
• fibrocystic disease (FBD), risk 47
• fight or flight response 357–358
• first trimester miscarriages, genetics (impact) 30
• focalism 295, 296
• focusing (MI process) 268
• follicle‐stimulating hormone (FSH) levels, alteration 28
• formal caring, need (older adults) 368
• frailty, increase (older adults) 367
• Framingham Risk Equation, risk calculator 85
• frontotemporal lobar degeneration 95
• frotteuristic disorder 390
• frozen embryo transfer (FET) 28
• frozen/thawed embryo transfer cycle 28
• Functional Assessment Measure (FAM) 238
• functional assessment, measurement ability 238
• functional capacity 187
• Functional Independence Measure (FIM) 238
• functional magnetic resonance imaging (fMRI), usage 47
• functional restoration (FR) programs 187–188
• fungal skin diseases 451
• future expectations, inaccuracy (increase) 294
• future ischemic heart disease, indicators 88

• gait disturbances 95
• gamma‐aminobutyric acid (GABA)
  • antagonists 464
  • inhibitory effects, enhancement 440
• gastric banding procedure 177
• gastric bypass 346
• gastric sleeve procedure 177–178
• gender dysphoria, psychologist treatment 351–352
• gender identity, assessment 385
• gender minorities
  • individuals, sexual risk behaviors (association) 422
  • persons
    • obesity, concern 422
    • substance use, elevation 421–422
  • term, usage 417
• general clinic supports 285
• generalized affective forecasts, importance 298–299
• generalized anxiety disorder (GAD) 452, 453
• general practice, organization 284–285
• genetic test results, obtaining (intentions) 48
• genital herpes 385
• genital stimulation, sexual interest 390
• glasses, usage (problems) 97
• gonorrhea 385
• grief
  • complicated grief, occurrence 31
  • expressions 30
• Guidelines for Assessment of and Intervention with Persons with Disabilities (APA) 275, 278
• Guidelines for Prevention in Psychology 36–37
• “Guidelines for Psychological Practices in Health Care Delivery Systems” (APA) 345
• guilt, feelings 193

• Hamilton Rating Scale for Depression (HAM‐D) 237, 239
• Handbook of Psychology and Health 183
• hangovers, experience 70
• headaches 131
  • acetaminophen (paracetamol), usage 134
  • chiropractic, usage 248
  • cluster headaches 138
  • medication overuse headaches 136
  • migraine headaches 134–137
  • nonsteroidal anti‐inflammatory drugs (NSAIDs), usage 134
  • tension headaches 131–134
• health
  • anxiety 452, 453–454
  • biopsychosocial (BPS) model 147
  • complications, binge eating disorder (association) 121
  • disease stigma, impact 57
  • disparities, minority stressors (relationship) 421–423
  • health‐compromising behavior, termination 24
  • health‐enhancing behavior, initiation 24
  • health‐enhancing changes, making 37
  • health‐promoting school, WHO definition 396
  • health‐related decisions, conscious/unconscious processes (impact) 53
  • health‐related examples 296
  • health‐related quality of life 336
  • information
    • attitudes (changes), self‐affirmation (impact) 50–51
    • resistance, overcoming 45
    • responsiveness (increase), self‐affirmation (impact) 53
  • literacy, patient level 218–219
  • maintenance 358
  • messages, self‐affirmation/responses 45
  • outcomes, structural stigma (influence) 60
  • prevention, relationship 41–42
  • problem, emergence 327
  • problems/diseases, chronic psychopathology (comorbidity) 316
  • providers, anti‐stigma approaches 61–62
  • psychologist, role 90–91
  • relationships, impact 19
  • research 46
  • risk behaviors 155
  • service psychology, societal/healthcare trends (impact) 356–357
  • sexual minority populations, impact 417
  • subjective perceptions, PTEs (association) 154
  • suicide, impact 207
• Health at Every Size (HAES) program 400
• health behavior
  • change, self‐affirmation process (understanding) 50–52
  • motivation, emotional well‐being (impact) 297–298
  • self‐affirmation, impact 46
• health belief model (HBM) 40–41
• healthcare
  • access 329
  • child access, disparities 330–331
  • contexts, challenging 350–351
  • delivery, psychologist competence/credentialing 347
  • ethnic minorities, relationship 329–331
  • factors 328–329
  • visits, occurrence 283
• health contexts
  • comorbidity 101
  • depression 101, 107
  • depressive relapse, examples 109–110
  • relapse 107
• Health Insurance Portability and Accountability Act (HIPAA) 288, 346
  • confidentiality control 348
• Health Management Resources weight‐loss program 174
• health promotion
  • CAM modalities, usage 246
  • health damage, contrast 51
  • protective factors 37–38
  • tier 1 (three‐tier model) 398–400
• health psychology
  • affective forecasting 293
  • biopsychosocial (BPS) approach, evolution 321–323
  • biopsychosocial (BPS) practice 321
  • clinical health psychology
    • history 355
    • trends 311
  • complementary, alternative, and integrative interventions 245
  • defining 357–361, 358
  • eating 395
  • exercise 407
  • hypnosis
    • applications 259–260
    • relationship 257
  • implications 83, 143
  • knowledge, translation 315
  • neurocognitive disorders, relationship 95
  • pain, relationship 1832
  • relationship 356–357
  • research advance 45
  • schools 395
  • sport 407
  • suicide 203
    • prevention 207–208
  • theory of suicide 204–205
  • three‐tier model, history 397–402
• healthy eating behaviors (facilitation), tier 2 (three‐tier model) 400–401
• Healthy People 2020 (publication/mission) 42, 356
• healthy physical activity 399
• healthy school, notion 395
• healthy student 397
  • approach, components 399
  • self‐care 397
• heart, comorbid depression/smoking (impact) 87–88
• hemorrhagic stroke, chronic drinking (impact) 437
• herbal supplements, usage 247
• heterosexism, experiences 418
• hierarchical attitudes, inclusion 277
• high blood pressure, chronic drinking (impact) 437
• high‐intensity exercise, impact 408–409
• home exercise program (HEP) 302–305
• homeopathy, usage 246
• homophobia, behaviors 418
• hopelessness, feelings 208
• HORIZONS (STI/HIV prevention intervention) 386
• hospice programs, Medicare/Medicaid funding 42
• Hospital Anxiety and Depression Scale (HADS) 208, 241
• human bodies, evolution 324
• human immunodeficiency virus (HIV) 383
  • antiretroviral (ARV) medications 387
  • care, test and treat 387
  • contraceptive methods 387–388
  • medical male circumcision 387
  • post‐exposure prophylaxis (PEP) drugs 387
  • pre‐exposure prophylaxis (PrEP) 387
  • prevalence 385–386
  • prevention intervention approaches 386–387
  • prevention methods 384
  • prevention toolkit, expansion 387
  • risk 384
    • increase 386
  • stigma, sensitivity 62
  • test 420
  • testing/linkage/retention 387
  • transmission risk, reduction 387
  • Truvada (emtricitabine/tenofovir disoproxil fumarate), FDA approval 387
  • vaccination 387
• human papillomavirus (HPV) 385
• Huntington disease, genetic test results (obtaining) 48
• Huntington's disease, depression (association) 236
• hyperhidrosis 451, 452
• hypersexual disorder 389
• hypersexuality 389–390
  • clinical guidelines/diagnostic criteria, absence 389
  • treatment, multi‐method 390
• hyperthyroidism, depression (association) 236
• hypnosis
  • applications 259–260
  • clinical hypnosis 257–258
  • experience, factors 258
  • health psychology, relationship 257
  • meta‐analyses 259
  • portability, increase 258
  • positive outcomes, perspective 258
  • qualitative reviews 259
  • sleep‐like state, contrast 257
  • usage 246, 253
• hypnotherapy, usage 229–230
• hypnotic suggestibility 258–259
• hypotension, bulimia nervosa (association) 121
• hypothalamic‐anterior pituitary‐adrenal (HPA) axis, allostatic load (manifestation) 156
• hypothalamic‐pituitary‐adrenal (HPA) axis, trigger 75
• hypothyroidism, depression (association) 236

• if‐then plans 49
• illness
  • biopsychosocial (BPS) model 147
  • definition 185
  • prevention 358
  • stigma, influence 59–60
• immune functioning, massage therapy (impact) 249
• immune neglect 296
• impact bias, research 295–296
• implementation intentions
  • self‐affirmation implementation intention 49
  • self‐affirmation, independent/synergistic effects 49
• impulsivity 204
• individuals (characteristics), self‐affirmation effects (moderators) 47–48
• indoor tanning, quitting (intentions) 49–50
• infectious disease, death rate (US) 323
• infertility 27–29
  • causes 28
  • emotional consequences 28
  • infertility‐specific mental health services 29
  • types 27–28
• informal caring, need (older adults) 368
• Information‐Motivation‐Strategy Model (IMS Model) 218
  • information element, impact 219
  • motivation, emphasis 220
  • strategies/resources, development 220
  • usage 219–220
• information processing, reduction 60
• informed consent 348–349, 429–430
• inhibitory emotion regulatory styles 156–157
• insomnia 459
  • actigraphy, usage 462
  • aromatherapy, usage 249
  • assessment 461–462
  • clinical interview 461
  • cognitive behavioral therapy for insomnia (CBT‐I) 462–463
    • pharmacotherapy, contrast 464–465
  • cognitive behavior therapy (CBT), adherence (improvement) 315
  • comorbidities 460–461
  • conceptualization, changes 460
  • daily sleep diaries, usage 461–462
  • diagnosis/epidemiology 459–461
  • impact 459–460
  • improvement 187–188
  • melatonin receptor agonists (MRAs) 464
  • orexin receptor antagonists (ORAs) 464
  • over‐the‐counter (OTC) medications 464
  • pharmacotherapy 463–464
  • polysomnography, usage 462
  • prescription medications, approval/nonapproval 464
  • prevalence 459–460
  • psychological interventions 462–463
  • questionnaires, usage 462
  • risk factors 460–461
  • treatment 462–465
  • tricycle antidepressants (TCAs) 464
  • types 460
• Insomnia Severity Index (ISI) 462, 463
• Institute of Medicine (IOM)
  • Living and Chronic Illness report 183
  • “Relieving Pain in America” report 184
• integrated care
  • definition 208–209
  • possibility, EHRs (impact) 348
• integrative health techniques, ethics issues 427
• intentional patient nonadherence 217
• intentions (engendering), self‐affirmation (impact) 51
• interdisciplinary care, multidisciplinary care (contrast) 185–186
• interdisciplinary pain management 185–187
  • models, effectiveness 186
• interdisciplinary pain programs
  • availability, improvement 186
  • heterogeneity 187
• interdisciplinary team
  • functioning, practice 276–277
  • science, research 278
• internal experiences, inhibition/avoidance/escape 156–157
• internalized stigma, reduction (efforts) 62
• International Classification of Headache Disorders (ICDH), International Headache Society creation 131
• Internet, obesity effects 173
• interpersonal psychotherapy (IPT) 108, 112
  • combinations, usage 108–109
  • interventions 109
  • usage 123
• interpersonal therapy (IPT) 198
• intervention strategies, self‐affirmation (combination) 48–50
• Interview for Diagnosis of Eating Disorders 445
• intimate partners, health problem prevention 20
• intrauterine insemination (IUI) 28
• in vitro fertilization (IVF) 28
• irritable bowel syndrome (IBS)
  • hypnosis, application 260
  • invitation avoidance 60
• ischemic heart disease 83
  • depression
    • negative effects 84–86
    • relationship, smoking (role) 87–90
  • depressive symptomatology 85
  • health psychologist, role 90–91
  • incidence/mortality, depression prediction 84–85
  • indicators 88
  • measurement 84
  • prediction, smoking (impact) 87
  • prevalence, estimate 83
  • primary/secondary prevention, comorbid risk factors (understanding/treatment) 83
  • promotion 85
  • psychological conditions/behavioral risk factors, relationship 83–84
  • risk, increase
    • depression mechanisms, impact (hypothesis) 85
    • depressive symptoms, chronic exposure/accumulation (impact) 86
  • risk (reduction), smoking cessation (impact) 90
  • societal implications 90–91
• ischemic stroke, chronic drinking (impact) 437
• Iyengar yoga 250

• Jenny Craig weight‐loss program 174
• job loss, impact 388
• Joint Principles of the Patient‐Centered Medical Home (PCMH) 208–209

• Kinect application 306–307
• knowledge acquisition, concentrations 279–280
• Korsakoff's syndrome, chronic drinking (impact) 437
• Kundalini yoga 250

• label avoidance, impact 60
• language
  • children, disparities 331
  • patient language, forms 266
• lesbian, gay, and bisexual (LGB), term (usage) 417
• lesbian, gay, bisexual, or transgender (LGBT) experience 385
• life events, affective forecasts (impact) 298
• lifespan, prevention/health 35
• lifestyle treatment effects, Diabetes Prevention Program (DPP) demonstration 175
• Likert scale 240, 446
• Liraglutide (Saxenda), usage 176–177
• liver diseases 438
  • alcoholic liver disease, treatment 441
• Living Well and Chronic Illness (IOM report) 183
• long‐term aspirations, actions (connections) 52
• Look AHEAD weight loss study 175
• lorcaserin (Belviq), usage 176
• lung disease risks (recognition), smoking (continuation) 297
• luteinizing hormone (LH), impact 28

• Maastricht Questionnaire 239
• macrosystem 328
• major depressive disorder, concept (combination) 108
• manipulative body practices 247
• massage
  • therapy 247, 249–250, 429
  • usage 133
• Matarazzo, Joseph 358
• Maudsley model of AN treatment for adults (MANTRA) 123
• Means‐End Problem Solving (MEPS) Procedure 238
• Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) 163
• medical culture, psychologists (interactions) 345–346
• medical disorders, anxiety disorders (comorbidity) 237
• medically assisted reproduction interventions, stress 29
• medically assisted reproduction technology, stress 29
• medically unexplained physical symptoms (MUPS) 207
• medical male circumcision 387
• medical nonadherence, addressing 346
• medical providers, relationships (management) 288–290
• medical psychology, intercultural skills 345–346
• medical regimens, adherence 217
• medical residents, stigma‐related concerns 59
• medical settings
  • psychological assessment, practice implications 235
  • psychologists, ethics issues 345
• medication
  • effects, monitoring 97–98
  • medication overuse headaches 136
  • regimens, adolescent nonadherence 376
• medication adherence
  • barriers 338
  • children 337–339, 375–376
    • barriers 375–376
  • older adults 366–367
  • promotion, interventions (impact) 338–339
• Medifast weight‐loss program 174
• meditation 400
  • usage 246–248
  • utility, demonstration 357–358
• melatonin receptor agonists (MRAs) 464
• memory
  • encoding 157
  • episodic memory, delay 14
  • semantic memory networks, activation (abnormality) 164
  • spatial working memory, decline 14
• men, cancer mortality 73
• mental health
  • deterioration 77
  • diagnoses, medical resident stigma‐related concerns 59
  • problems, risk 38–39
  • professionals
    • adaptability/skill, importance 346
    • professional integrity 346–347
  • services/interventions, caregiver usage (barriers) 14
• Mental Health Parity Act, mental illness insurance coverage (expansion) 609
• mental illness
  • biogenetic explanations, blame/dangerousness (associations) 61
  • development, absence 154
  • insurance coverage expansion, Affordable Care Act/Mental Health Parity Act (impact) 60
  • suicide risk, association 207–208
• men who have sex with men (MSM), HIV (impact) 385
• meridians 251
• mesosystem 327–328
• metatheoretical frameworks, psychology reliance (reasons) 322
• mHealth programs, impact 173
• microbicides, usage 387
• microsystem 327–328
• middle childhood, developmental milestones 332
• migraine headaches 134–136
  • acupuncture 137
  • aura phase 135
  • biofeedback, usage 137, 252
  • cognitive behavioral treatment (CBT) focus 137
  • electrical activity, spread 135
  • etiology 136
  • headache phase 135
  • mindfulness‐based methods 137
  • pathophysiology 135–136
  • pharmacological treatment 136
  • phases 135
  • process 135
  • psychotherapy treatments 137
  • symptomology, reasons (debate) 135
  • transcranial magnetic stimulation (TMS) 136
  • treatments 136–137
  • triggers 135
  • warning phase 135
• military active duty psychologists, impact 350
• Millennium Development Goals (MDGs), creation 209–210
• mind‐body connection (suicide) 207
• mind‐body medicine 246
• mindful awareness, usage 400
• mindfulness 399
  • mindfulness‐based therapy, potential 109
• mindfulness‐based cognitive therapy (MBCT) 198, 248
• mindfulness‐based stress reduction (MBSR) 248
• minority identity 420–421
  • stress processes, association 420
• minority statuses
  • environmental circumstances, impact 420
  • intersectional interactions 419
• minority stress
  • experiences 421
  • framework, usefulness 419
  • model 418, 421
• minority stressors, health disparities (relationship) 421–423
• minors, gender dysphoria 351–352
• miscarriage 27, 29–32
  • complicated grief, occurrence 31
  • disappointment/despair 30
  • first trimester miscarriages, genetics (impact) 30
  • incidence 30
  • risk (increase), anorexia nervosa (association) 121
  • risk factors 30
• monoamine oxidase inhibitors (MAOIs), usage 125
• mood
  • inconsistent information, processing 157
  • Profile of Mood States (POMS) 408
  • rehabilitation domain 187
• morbidity
  • multi‐morbidity 365–366
  • patterns, change (US) 323–324
• mortality pattens, change (US) 323–324
• mothers, pregnancy (depression) 194
• motivational enhancement therapy (MET) 269
• motivational interviewing (MI) 265
  • applications/adaptations 269–270
  • autonomy supportive characteristic 267
  • collaboration, spirit 267
  • evidence base 268–269
  • evocative characteristic 267
  • microskills 267
  • patient language perspective 266
  • principles 41
  • processes 268
  • skills/strategies 267–268
  • style/spirit 266–267
  • training 269
  • usage 439
• motivation, construct (complexity) 165
• motor skills, decrease 95
• multidisciplinary care, interdisciplinary care (contrast) 185–186
• Multi‐Ethnic Study of Atherosclerosis (MESA) calcium calculator 84
• multi‐morbidity 365–366
  • consequences 366–370
• multiple relationships 430–431
• multiple sclerosis (MS) 207
  • behavioral approaches 148
  • caregiver study 11–12
  • depression/depressive symptoms, psychological manifestations 144
  • depressive symptoms, impact 145
  • functional impairment, physical disease (distinction) 148
  • relapsing‐remitting multiple sclerosis (RRMS), study 146–147
  • Theory of Unpleasant Symptoms (TOUS) 145–146
  • walking/depression, health psychology implications 143
• Multiple Sclerosis Walking Scale‐12 (MSWS‐12) 143
• Muscle Appearance Satisfaction Scale 447
• muscle tightness/strain (reduction), massage therapy (usage) 249
• musculoskeletal pain (reduction), aerobic/strengthening exercises (impact) 410
• music therapy, usage 246, 253

• naltrexone/bupropion (Contrave), usage 176
• National Alliance for Caregiving (NAC), family caregiver report 9
• National Association of School Psychologists (NASP), school multitier model 398
• National Center for Complementary and Integrative Health, Clinical Digest 229
• National Epidemiological Survey on Alcohol and Related Conditions III data 68
• National Health and Nutrition Examination Survey (NHANES), obesity data 171–172
• National Health Interview Survey 246
• National Institute of Mental Health (NIMH), schizophrenia initiatives 163
• National Institutes of Health (NIH)
  • “National Pain Strategy” 184
  • Patient‐Reported Outcomes Measurement Information System (PROMIS) 186–187
• “National Pain Strategy” (NIH) 184
• National Society of Crippled Children and Adults 273
• National Weight Control Registry (NWCR), obesity cohort 173–174
• naturopathy, usage 246
• neck pain (treatment), chiropractic (usage) 248
• negative affect
  • negative emotionality 119
  • persistence 194
• negative attitudes, reduction 61–62
• neonatal loss (stillbirth) 27, 29–32
  • causes 30
  • complicated grief, occurrence 31
  • disappointment/despair 30
• neural activity
  • excess disability, prevention 96–98
  • message processing, impact 52–53
  • self‐affirmation, impact 46–47
• neural networks, organization 155–156
• Neurobehavioral Rating Scale (NRS) 239
• neurocognitive disorders (NCDs)
  • comorbidities, detection/management 97
  • dementia/delirium, recognition/management 98
  • dependencies 96
  • depression/anxiety, prevention/addressing 98
  • etiology 95
  • family care partners, health (promotion) 98–99
  • health psychology
    • relationship 95
    • role 96
  • medication effects, monitoring 97–98
  • patterns 905
  • prevention/management (importance), American Academy of Neurology Ethics and Humanities Subcommittee emphasis 96–97
  • problems, coping 96
  • progression 99
  • quality of life, basic functioning (optimization) 97
  • substance use, detection/reduction 98
• neurodegeneration, changes 95
• neurodegenerative disease, progressive effects (acceleration) 98
• neurons, organization 155
• neuropsychological evaluation, usage 274
• nicotine
  • dependence 227
  • electronic nicotine delivery systems (ENDS), marketing 223
  • gum, development/usage 227–228
  • term, usage 223
  • use disorders 225
• nicotine replacement therapy (NRT), modalities 228
• Nicot, Jean 224
• nociception, pain (contrast) 185
• nonclinical depression, reduction 408–409
• noncommunicable diseases, mortality reduction (United Nations Sustainable Development Goals) 90–91
• non‐orthopedic pain conditions 187
• nonsteroidal anti‐inflammatory drugs (NSAIDs), usage 134
• no‐show appointments, allowance 346

• obesity 171
  • adjustable gastric band, usage 177
  • bariatric surgery 177–178
  • behavioral lifestyle interventions 174–175
  • biliopancreatic diversion, duodenal switch (usage) 178
  • BMI definition 172
  • clinical guidelines 178
  • commercial weight‐loss programs 174
  • consequences 172
  • daily caloric intake, goal setting 174
  • environmental contributors 172–173
  • etiology 171–173
  • extended care maintenance programs, helpfulness 174
  • genetic contributors 172–173
  • hypnosis, application 260
  • influences 172–173
  • Internet, effects 173
  • lifestyle treatment effects, Diabetes Prevention Program (DPP) demonstration 175
  • liraglutide (Saxenda), usage 176–177
  • lorcaserin (Belviq), usage 176
  • medical costs 172
  • mHealth interventions 173
  • naltrexone/bupropion (Contrave), usage 176
  • National Health and Nutrition Examination Survey (NHANES) data 171–172
  • National Weight Control Registry (NWCR) cohort 173–174
  • obesity‐related comorbidity 175
  • orlistat (Xenical), usage 175–176
  • pharmacotherapy 175–177
  • phentermine/topiramate (Qsymia), usage 176
  • prevalence, increase 171
  • rates, increase 327
  • risk (increase), pediatric cancer (impact) 339–340
  • roux‐en‐ϒ gastric bypass 177
  • scope/seriousness 171–173
  • self‐help approaches 173–174
  • treatment options 173–178
  • vertical sleeve gastrectomy, usage 177–178
  • weight loss, Look AHEAD study 175
• obesogenic environment 173
• obsessive‐compulsive disorder (OCD) 452, 454–455
• offset responsibility 60–61
• offspring, postpartum depression 194–195
• older adults
  • behavioral medicine researchers/clinicians, perspectives 365
  • chronic physical health problems, depression management 369–370
  • cognitive behavior therapy, usage 370
  • disability, increase 367
  • falling, fear 368–369
  • fatigue, management 367
  • formal/informal caring, need 368
  • frailty, increase 367
  • health psychology researchers/clinicians, perspectives 365
  • medication adherence 366–367
  • pain, management 367
  • physical activity, reduction 369
  • problem‐solving therapy, usage 370
  • shoulder impairment, epidemiology 301–302
• olfactory/taste perception, alteration 97
• Olmstead v. L.C. 60
• oncology
  • primary care setting 240–241
  • survivorship, periods 240
• onset responsibility 60–61
• OPTIFAST weight‐loss program 174
• oral contraceptives, effectiveness (ASHA data) 387
• orexin receptor antagonists (ORAs) 464
• organ transplantation 346
  • assessment 241
  • primary care setting 240
  • psychologists, services 350–351
• orlistat (Xenical), usage 175–176
• osteopathic 247
• osteopenia, anorexia nervosa (association) 121
• osteoporosis 369
  • anorexia nervosa, association 121
• oxytocin augmentation therapy (OAT), meta‐analysis 166

• pain
  • aromatherapy, usage 249
  • biopsychosocial (BPS) model 184–185
  • coping 187
  • functional restoration (FR) programs 187–188
  • health psychology, relationship 183
  • interdisciplinary pain management 185–187
    • effectiveness 186
  • measurement 303
  • nociception, contrast 185
  • relief, hypnosis (applications) 259
  • VA Polytrauma Network Site, veteran assessment 188
• pain management
  • care, multicomponent models 185
  • older adults 367
  • services, integration (importance) 186
• panic, agoraphobia (relationship) 455
• paracetamol (acetaminophen), usage 134
• paraphilic disorders 390–391
  • assessment, clinician investigation 390
• parasympathetic nervous system activity, decrease 85
• Parkinson's disease
  • depression, association 236
  • patients, caregiver study 10
• partial hospitalization programs (PHPs), ED treatment option 126
• partners
  • influence, characteristics 22
  • negative tactics, usage 24
• pathological worry, impact 453
• patient adherence (compliance) 217
  • factors 218–219
  • improvement, IMS Model (usage) 219–220
  • Information‐Motivation‐Strategy Model (IMS Model) 218
• Patient‐Centered Outcomes Research Institute (PCORI), clinical trials requirement 298
• Patient Health Questionnaire 9 (PHQ‐9) 198
• patient nonadherence
  • economic burden 217–218
  • types 217
• Patient Protection and Affordable Care Act (US ACA) 36, 38, 359, 361
  • insurance coverage expansion 60
  • prevention, relationship 38–39
• Patient‐Reported Outcomes Measurement Information System (PROMIS) (NIH) 186–187
• patients
  • informed consent 429–430
  • patient language, forms 266
  • self‐prescribing 428–429
• pediatric cancer
  • depression/anxiety, relationship 336
  • diagnosis, family adjustment 337
  • health‐related quality of life 336
  • impact 339–340
  • medication adherence 337–339
  • negative psychosocial outcomes 336–337
  • psychosocial functioning 335–337
  • resiliency 336–337
  • survivorship, health challenges 339–340
  • treatment, neurological functioning 339
• pediatric illnesses (treatment), telemedicine (usage) 377–378
• pediatric psychologists, roles 376–377
• pediatric psychology
  • cultural/ethical disparities 378
  • culturally competent care 378
  • definition 373
  • diagnosis, adjustment 374–375
  • interventions, impact 374–375
  • treatment delivery 376–377
• pedophilic disorder 390
• peers, transformational leadership qualities 411
• pelvic inflammatory disease (PID) 385–386
• perfectionistic tendencies 119–120
• performance‐enhancing substances, impact 412
• pericranial muscles, tenderness (impact) 132
• perinatal depression 193
  • biological factors 195–196
  • clinical history/comorbidity 197
  • cognitive behavioral therapy (CBT) 198
  • complementary and alternative medicine (CAM) 199
  • conceptualization/classification 193–194
  • demographic factors 195
  • detection 197–199
  • development timing, impact 196
  • engagement 197–198
  • health factors 195–196
  • interpersonal therapy (IPT) 198
  • management 197–199
  • mindfulness‐based cognitive therapy (MBCT) 198
  • prevention 198–199
  • prophylactic treatment 198
  • protective factors 195–197
  • psychological factors 196–197
  • psychotherapy, usage 198–199
  • risk 195–197
    • health‐related behaviors, impact 196
  • screening 197–198
  • social support, importance 196–197
  • socioeconomic status (SES), factor 195
  • SSRI, usage 198
  • treatment 198–199
• perinatal loss
  • aftermath 31–32
  • factors 30
  • grief reaction 30
  • interventions, consensus (absence) 31–32
  • mental health disorders 31
  • psychotherapy/counseling 31
• permission, implication 349
• personality
  • characteristics, assessment 37
  • complexity 409
• personal wellness, improvement 36
• person‐centered theory (PCT) 39
• phentermine/topiramate (Qsymia), usage 176
• phobias (treatment), chiropractic (usage) 248
• physical activity
  • anxiety‐reducing effects 408
  • cause 407–410
  • concurrent factors 411–413
  • effect 410–411
  • effectiveness 408
  • feelings 408
  • healthy physical activity 399
  • participation, barriers 413
  • psychobiological factors, relationship 409–410
  • reduction, older adults 369
• physical health
  • potentially traumatic events (PTEs), exposure
    • association 154–155
    • impact 153
  • problems, risk 38–39
• physical therapy (PT) 276, 302–305
• physicians
  • board certification 347
  • patient trust level, importance 219–220
• Pittsburgh Sleep Quality Index (PSQI) 462, 463
• placental abruption 30
• planned behavior (PB) 40
• planning (MI process) 268
• pleasure, experience capacity (reduction) 163–164
• polycystic ovary syndrome (PCOS) 28
• polysomnography, usage 462
• positive/negative social control, contrast 21
• positive psychology
  • research 278
  • usage 38
• post‐caregiving 14–15
• post‐exposure prophylaxis (PEP) drugs 387
• postpartum depression
  • correlates/consequences 194–195
  • deficiencies, association 196
• postpartum depressive symptoms, unhealthful behaviors (association) 196
• posttraumatic growth (PTG) 11
  • caregiver, patient‐related factors (relationship) 11
  • experiences 421
  • research 278
• posttraumatic stress disorder (PTSD) 188, 452, 454
  • lifetime prevalence 154
  • PTE exposure, poor health (association) 155
• posttraumatic stress, levels (increase) 335
• potentially traumatic events (PTEs)
  • biology, negative alterations (association) 153
  • emotional pain, distance 157
  • exposure
    • health problems, association 155
    • impact 153, 156
    • physical health, association 154–155
  • health, subjective perceptions (association) 154
  • inhibitory emotion regulatory styles 156–157
  • posttraumatic stress disorder (PTSD), relationship 153–154
  • psychopathological syndromes, development 154
  • responses 154
• poverty, long‐term impact 329
• Practice Guidelines (APA) 124
• prayer, usage 246, 247, 251
• preeclampsia 30
• pre‐exposure prophylaxis (HIV) 387
• pre‐exposure prophylaxis (PrEP) 387
• preference‐sensitive decisions
  • affective forecasting, impact 2907
  • example 296
  • influences 296–297
• preference‐sensitive prevention/treatment decisions, affective forecasting (role) 296–297
• pregnancy
  • achievement, medical procedures 28–29
  • alcohol consumption, detrimental outcomes 438
  • depression, correlates/consequences 194–195
  • prevention methods, usage 384
• premature death, obesity (association) 172
• premature ejaculation 388
• premature ischemic heart disease morbidity/mortality risk (increase), cigarette smoking (impact) 87
• Preparing People for Change 265
• Preparing People to Change Addictive Behaviors 265
• preterm delivery, risk (increase) 194–195
• prevention
  • activities 36–37
  • Affordable Care Act, relationship 38–39
  • definitional terms (Gordon), US Institute of Medicine's Committee on Prevention of Mental Disorders adoption 36
  • definitions 35–36
  • guidelines 36–37
  • health belief model (HBM) 40–41
  • health, relationship 41–42
  • intervention, conceptualization 36
  • motivational interviewing (MI) 41
  • psychological‐based theoretical interventions 39–41
  • research/practices 37
  • science, evidence 36
  • specialists, impact 37
  • theory of reasoned action and planned behavior (TTA/PB) 40
  • three‐tier model, history 397–402
  • training 37
  • transtheoretical model of behavior change (TTM) 39–40
  • types 35–36
• primary care health settings, anxiety disorders (screening) 237
• primary care medicine, suicide (context) 205–209
• primary care physician (PCP)
  • healthcare visits, occurrence 283
  • referral management 286–287
  • referral placement, promotion 287
• primary care psychology, administrative issues 283
• primary care settings 236–238
  • behavioral health providers, involvement 283–284
  • drug/alcohol abuse, concerns 237–238
  • rehabilitation settings 238–239
  • specialty settings 239–241
• primary infertility, occurrence 27–28
• primary insomnia 460
• primary medical care (PC)
  • BHP work 284
  • definition 283
• primary prevention 35
• primary psychiatric disorders 451
• problem behaviors, reduction 37
• problems, aversion 36
• problem‐solving skills training (PSST) 375
• problem‐solving therapy 370
• Profile of Mood States (POMS) 408
• progressive muscle relaxation (PMR) 247, 250–251
• Project MATCH 269
• prostate‐specific antigen (PSA) testing, prostate cancer screening (USPSTF recommendations) 75
• protective factors
  • considerations 38
  • types 37
• psoriasis 451
• psychiatric comorbidity 227, 388
• psychiatric disorders 187
• psychobiological factors, physical activity (relationship) 409–410
• psychodermatological (psychocutaneous) disorders, classification 451
• psychodermatology, impact 451
• psychological conditions, cataloguing 451–452
• psychological disorders
  • development, risk (increase) 366
  • protective/risk factors, association 331
• psychological immune system 294
• psychological practice, CAM integration 433–434
• psychological services, assessment/provision (importance) 275
• psychological stress, coping 238
• psychological treatment, complementary/alternative/integrative health techniques (ethics issues) 427
• psychologists
  • advertising 431–432
  • boundaries 349–350
  • boundaries, rules/structures 430–431
  • CAM modality knowledge, necessity 429
  • clinical competence 428–429
  • competence/credentialing (healthcare delivery) 347
  • confidentiality 348
  • ethics issues (medical settings) 345
  • gender dysphoria treatment 351–352
  • growth 358–359
  • healthcare contexts, challenging 350–351
  • informed consent 348–349
  • loyalties, conflicts 351
  • military active duty psychologists, impact 350
  • multiple relationships 430–431
  • primary care integration 283
  • professional colleagues, consultation/cooperation 431
  • professional integrity 346–347
  • public statements 431–432
  • services (organ transplantation) 350–351
  • transgender youth treatment 351–352
• psychology
  • health, relationship 356–357
  • medical psychology, intercultural skills 345–346
  • pediatric psychology 373
  • positive psychology, usage 38
  • prevention, guidelines 36–37
  • professional organizations, formation 357–361
  • role 204
• psychomotor agitation/retardation 193
• psychoneuroimmunology (PNI) 357
• psycho‐oncology, cancer (relationship) 73
• psychophysiologic disorders 451
• psychosexual functioning, evaluation 274
• Psychosocial Assessment of Candidates for Transplantation (PACT) 240
• psychosocial stressors (reactivity reduction), exercise/physical activity (impact) 410
• psychosocial triggers, impact 75
• psychotherapy
  • migraine headache treatments 137
  • usage 198–199
• public health, three‐tier model (history) 397–402
• public statements (psychologists) 431–432

• qigong 247
• quality of life
  • basic functioning, optimization 97
  • health‐related quality of life 336
  • reduction
    • obesity, association 172
    • walking impairment, association 145
• quality of life questionnaire (QLC‐C30) 241
• Quality of Life Scale 239, 241

• randomized controlled trials (RCTs) 230, 257, 313, 369
• range of motion (ROM)
  • change 305
  • dynamic record 306
  • feasibility testing, proof‐of‐concept trial 306
  • measurement 303
  • normal ROM 303
  • recovery, optimization 302
  • shoulder ROM, recovery (patient expectations) 306
• rapid eye movement (REM) sleep
  • acute exercise, impact 409–410
  • onset delay, alcohol (impact) 69–70
• Raynaud's disease, biofeedback (usage) 252
• Readiness for Transition Questionnaire (RTQ) 240
• readiness rulers 267–268
• real‐world situations, limitations 315
• recreational sport, team size (negative impact) 411
• rehabilitation
  • black box perspective 277
  • interventions, theory‐driven framework (development) 276
  • psychologists
    • advocate roles 278–279
    • roles 273–277
  • settings 238–239
• rehabilitation psychology 273
  • interdisciplinary team functioning, practice 276–277
  • intervention, practice 275–276
  • petition 279–280
  • practice, assessment 274–275
  • research 277–279
  • training 279–280
• reiki 247, 252
• relapsing‐remitting multiple sclerosis (RRMS), study 146–147
• relationships
  • change, cognitions/readiness 22
  • close relationships 19
  • gender, impact 23
  • impact 19
  • multiple relationships 430–431
  • satisfaction 23
  • social relationships (breakdown), stigma (impact) 60
• relaxation
  • systematic relaxation 400
  • training, usage 133, 462–463
  • utility, demonstration 357–358
• “Relieving Pain in America,” IOM report 184
• religion, usage 247, 251
• reproductive consequences, anorexia nervosa (association) 121
• reproductive health 383
• reproductive trauma 31
• resilience (concept), utility (question) 421
• resistance, handling (MI principle) 41
• Resources for Enhancing Alzheimer's Caregiver Health (REACH) initiative/study 13
• risk
  • aversion 277
  • factor, definition 331
  • reduction 38
    • health‐enhancing changes, making 37
• ritualistic behaviors 454
• Rogers, Carl 265
• rosacea 451, 452
• rotator cuff injury 303
• roux‐en‐ϒ gastric bypass, usage 177

• schizophrenia 161
  • anhedonia, understanding 163–164
  • assessment, implications 165–166
  • avolition, impact 164–165
  • cognitive deficits 162–163
  • cognitive impairments, severity 162
  • dynamic psychological processes, data 165–166
  • ecological momentary assessment (EMA) 165–166
  • effort‐based performance deficits, pattern 165
  • effort deficits 164–165
  • emotion abnormalities 163–164
  • motivation 164–165
  • oxytocin augmentation therapy (OAT), meta‐analysis 166
  • prodromal (prepsychotic) features 164–165
  • psychiatric/functional impairment 166
  • treatment, acupuncture (usage) 252
  • treatment as usual (TAU) 167
  • treatment, implications 166–167
• Schofield, William 358
• schools
  • eating disorder prevention intervention, design/study 401
  • education, prevention model framework 398
  • Health at Every Size (HAES) program 400
  • health‐promoting school, WHO definition 396
  • health promotion
    • issues 396
    • system/community/school‐level factors 396
  • health psychology 395
  • healthy school, notion 395
  • lunches, provision 399
  • setting, impact 395–396
  • social emotional learning (SEL) programs 399
  • well‐being/health, promotion 399
• Screening, Brief Intervention, and Referral to Treatment (SBIRT) models 268, 270
• secondary infertility, occurrence 27–28
• secondary insomnia 460
• secondary prevention 35–36
• secondary psychiatric disorders 451
• seizure
  • disorders, depression (association) 236
  • management, benzodiazepines (effectiveness) 440
• selective serotonin reuptake inhibitors (SSRIs), usage 125, 134, 198
• self‐affirmation 45
  • effectiveness, considerations 47–48
  • effects, moderators 47–48
  • experimental induction 48
  • implementation intention
    • combination 50
    • independent/synergistic effects 49
    • intervention, development 49
  • influence 53
    • studies 46–47
  • intervention strategies, combination 48–50
  • message
    • content 47–48
    • framing, impact 49
  • process, understanding 50–52
  • research 46
  • single potential mediating variables, role 51
  • studies, research methods (diversity/application) 46–47
  • techniques, clinical samples 50
  • trajectory 52–54
• Self as Anchor, factor 304
• self‐care 399
  • tier 2 (three‐tier model) 400–401
• self‐efficacy, support (MI principle) 41
• self‐esteem
  • physical activity, impact 409
  • premorbid sources 275
• self‐focus, increase 194
• self‐management
  • resource access (restriction), label avoidance (impact) 60
• self‐management, stigma (influence) 59–60
• self‐monitoring, improvement 14
  • meditational model 21
• self‐protective responses, emergence 98
• self‐prototypes 305–306
  • deviations 304
• self‐related processing, increase 52–53
• self‐report‐based measures, usage 165–166
• self‐reported anhedonia, emotion regulation deficits (impact) 164
• semantic memory networks, activation (abnormality) 164
• sensory loss, correction (barrier removal) 97
• serotonin‐norepinephrine reuptake inhibitors (SNRIs), usage 134
• service utilization 238
• severe clinical depression, depressive symptoms (clarifications/distinctions) 111
• severe stress, experience 155
• sexual arousal, alcohol intake (impact) 69–70
• sexual behaviors 384
  • engagement 391
• sexual desire, absence 389
• sexual dysfunction 388–389
  • assessment, factors 388–389
  • gender specificity 388
• sexual functioning, restoration 389
• sexual/gender minority health, focus 110
• sexuality
  • attitudes 388
  • hypersexuality 389–390
• sexually transmitted diseases (STDs), medical resident stigma‐related concerns 59
• sexually transmitted infections (STIs) 383
  • contraceptive methods 387–388
  • infection methods 384
  • prevalence 385–386
  • prevention intervention approaches 386–387
  • risk, increase 386
• sexual masochism disorder 390
• sexual minority
  • health disparities, context 418–420
  • populations, health (relationship) 417
• sexual orientation 384–385
  • disordered eating, correlation 121
  • minority persons, research 419
  • minority, term (usage) 417
  • persons
    • obesity, concern 422
    • substance use, elevation 421–422
  • sexual risk behaviors, association 422
• sexual pleasure, experience (restoration) 389
• sexual risk behaviors 385–386
• sexual sadism disorder 390
• sexual trauma, negative health consequences 154
• shoulder impairment
  • baseline 306
  • epidemiology (older adults) 301–302
  • feasibility testing, proof‐of‐concept trial 306
  • home exercise program (HEP), usage 302–303
  • Kinect application 306–307
  • management
    • approach 302
    • efficacy 302–303
    • examination, CSM framework 303–304
  • outcomes
    • physical therapy, impact 306
    • self‐prototypes/expectations/timelines 305–306
    • timelines/expectations, technology (usage) 306–307
  • physical therapy (PT), usage 302–303
  • range of motion, dynamic record 306
  • self‐prototypes 304–305
    • semi‐structured interviews 305
  • stick avatar, usage 306
• shoulder ROM, recovery (patient expectations) 306
• single‐occasion interview‐based measures, usage 165–166
• single potential mediating variables, role 51
• Situational Inventory of Body Image Dysphoria 446
• skin cancer 451
  • risk, reduction 51
• skin disease, anxiety (relationship) 451
• skin‐mind connection, psychodermatology (impact) 451
• skin symptoms, responses/management 454–455
• sleep
  • daily sleep diaries, usage 461–462
  • disorder (insomnia) 459
  • disruption 193
    • alcohol consumption, impact 69–70
  • hygiene 463
    • problems 327
  • maintenance difficulties 459
  • restriction 462–463
  • sleep‐wake cycle, maintenance 97
  • sleep‐wake rhythms, changes 95
  • total sleep time (TST) 461, 463
    • improvement 464
  • wake time after sleep onset (WASO) 461
• sleep efficiency (SE) 461–462, 463
• sleep latency (SL) 461
• smoke break, avoidance 228
• smoking
  • cigarette smoking, impact 87
  • coronary artery calcification, relationship 88–90
  • depression, comorbidity 87
  • depression‐smoking comorbidity, recognition/treatment 90
  • dose‐dependent predictor 87
  • emotion, association (traits) 87
  • health risk behavior 155
  • impact 87–88
  • smoking‐related illnesses, mortality risk (increase) 226–227
  • status, breath samples (carbon monoxide analysis) 314–315
  • tobacco smoking 83–84
• smoking cessation
  • assessment, clinical areas 227
  • hypnosis, application 260
  • impact 90
  • programs, depressed smokers (treatment) 103
• social anxiety disorder (SAD) (social phobia) 452–453, 455
• social cognition, definition 162
• social control 20–21
  • attempts
    • history 24
    • neuroticism 24
  • contextual model 22–24
  • delineation, attempts 21
  • dual‐effects hypothesis 20–21
  • ethnic differences 23
  • gender, impact 23
  • positive/negative social control, contrast 21
  • usage, predictors/consequences 22
• social emotional learning (SEL) programs 399
• social justice 316–317
• Social Problem Solving Inventory‐Revised (SPSI‐R) 238
• social relationships (breakdown), stigma (impact) 60
• social support 20
  • contextual model 22–24
  • ethnic differences 23
  • exerciser perceptions 411
  • social control, relationship 22
• Society for Prevention Research 36
• Society of Counseling Psychology (APA) 36
• socioeconomic status (SES)
  • impact 329
  • perinatal depression factor 195
• Solomon, George F. 357
• spatial working memory, decline 14
• specialist supportive clinical management (SSCM) 123
• specialty settings 239–241
• spinal manipulation 247
• spirituality, usage 246, 247, 251
• sport
  • activities, direct parental involvement 411
  • cause 407–410
  • concurrent factors 411–413
  • effect 410–411
  • health psychology context 407
  • injury rehabilitation, adherence 410
  • participation, impact 409
  • recreational sport, team size (negative impact) 411
  • transformational leadership qualities 411
• Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) 240
• stigma
  • combatting 61–62
  • components 57
  • co‐occurring disease‐related stigmas, concern 62
  • definitions/examples 58
  • harm 60
  • impact 59–60
  • internalized stigma, reduction (efforts) 62
  • moderators 60–61
  • reduction 61
  • structural stigma, influence 60
  • types 58, 58–59
• stillbirth 27
• stimulus control 462–463
• stress
  • acculturative stress, impact 120–121
  • adjustment (improvement), interventions (usage) 374–375
  • aromatherapy, usage 249
  • chronic stress, body system (burden) 156
  • coping, assistance 20
  • dysregulated stress reactions 155–156
  • emotional stress, prevention 42
  • mindfulness‐based stress reduction (MBSR) 248
  • processes, minority identity (association) 420
  • reactions, mitigation 20
  • severe stress, experience 155
• stressors
  • chronic stressors 418–419
  • coping 20
  • minority stressors, health disparities (relationship) 421–423
  • psychosocial stressors (reactivity reduction), exercise/physical activity (impact) 410
  • traumatic classification 153–154
• structural stigma, influence 60
• Structured Interview for Anorexia and Bulimic Disorders 445
• students. See healthy student
  • eating problems, assessment/support (Tier 3) 401–402
  • healthy student 397
  • SCOFF screening instrument 401
• Study of Women's Health Across the Nation Heart Study 86
• Substance Abuse and Mental Health Services Administration (SAMHSA), binge drinking definition 69
• substance use 204
  • detection/reduction 98
  • disorders
    • classification, DSM change 67
    • eating disorders, relationship 122
  • elevation (sexual orientation/gender minority persons) 421–422
  • genetic risk factors 312, 314
  • health risk behavior 155
• subthreshold depressive symptoms, concepts (combinations) 108
• subthreshold ischemic heart disease, indicators 88
• suicidal ideation
  • levels, elevation 419
  • risk, elevation 335–336
• suicide
  • biopsychosocial (BPS) perspective 204–205
  • cognitions, reduction 208
  • cognitive behavioral therapy (CBT) 208
  • contagion 207
  • dialectical behavior therapy (DBT) 208
  • evidence‐based psychological treatment approaches 208
  • health psychology
    • context 203
    • theory 204–205
  • impact 207
  • integrated care 208–209
  • integrative care 212
  • The Joint Commission, recommendations 211
  • lifespan, perspective 205
  • mind‐body connection 207
  • prevention
    • changes 209–210
    • health psychology, impact 207–208
  • primary care medicine
    • context 205–209
    • presentation 206
    • training 206
  • psychologists, role 209
  • risk
    • identification 208
    • mental illnesses, association 207–208
  • suicidal behavior, occurrence 212
  • thoughts 193
  • World Health Organization (WHO)
    • global goals 209–210
    • recommendations 210–211
• survivorship
  • pediatric cancer 339–340
  • periods 240
• sustainable development goals (SDGs), UN presentation 209–210
• sustain talk 266, 267
• sweets, human craving 324
• sympathetic‐adrenal‐medullary (SAM) system, allostatic load (manifestation) 156
• sympathetic nervous system activity, increase 85
• syphilis 386
• System 1 (cognitive processing type) 324–325
• System 2 (cognitive processing type) 324–325
• systematic relaxation 400

• task, persistence 60
• telemedicine, usage 377–378
• telephone‐linked computer intervention 13
• temporomandibular joint dysfunction (TMJD), TTH occurrence (likelihood) 133
• temporomandibular (jaw) joint, impact 133
• tension headaches 131–134
  • epidemiology 131–132
  • etiology 132–133
  • treatments 133–134
    • biofeedback, usage 252
• tension‐type headache (TTH) 131
  • biofeedback training, treatment 133
  • cognitive behavioral therapy, efficacy 133
  • diagnostic criteria 132
  • etiology 132–133
  • manual therapy, usage 133
  • pericranial muscles, tenderness (impact) 132–133
  • relaxation training, usage 133
  • temporomandibular (jaw) joint, impact 133
  • treatment 133–134
• tertiary prevention 35–36
• The Joint Commission, suicide recommendations 211
• theory of reasoned action and planned behavior (TTA/PB) 40
• Theory of Unpleasant Symptoms (TOUS) 145–146
• therapeutic touch 247
• thinness, pursuit 396
• threat
  • bodily/physiological response 46
  • processing, openness 47
• threatening information, aversion (reduction) 51
• three‐tier model, history 397–402
• Timed 25‐Foot Walk (T25FW) 143
• time in bed (TiB) 461–462
  • restriction 463
• tobacco
  • abuse, term (usage) 225
  • companies, youth targeting 224–225
  • dependence, treatment 269
  • term, usage 223
• tobacco smoking 83
  • depression, relationship 83–84
  • role 87–90
• tobacco use
  • absence, health improvements 226–227
  • cessation
    • benefits 226–227
    • symptoms 226
  • cleaner smoke, design 224
  • e‐cigarettes, components 224
  • history 224–225
  • initiation/maintenance 226
  • reduction, symptoms 226
  • studies 224–225
• tobacco use disorder
  • acupuncture 230
  • assessment 227
  • behavioral therapy 228–229
    • relapse prevention 229
  • classification 225–226
  • complementary and alternative treatments 229–231
  • confectionary chewing gum 230–231
  • DSM‐5 definition 225
  • evidence‐based treatment 227–229
  • hypnotherapy 229–230
    • randomized controlled trial (RCT) 230
  • pharmacotherapy 227–228
  • symptoms 225
  • tolerance/withdrawal, constructs (association) 225–226
  • treatment 223
• topiramate, usage 176
• total sleep time (TST) 461, 463
  • improvement 464
• Traditional Chinese medicine (TCM) 245, 246, 251
• transcranial magnetic stimulation (TMS), effectiveness 136
• transformational leadership qualities 411
• transgender youth, gender dysphoria (psychologist treatment) 351–352
• transtheoretical model (TTM) 39–40
• transvestic disorder 390
• trauma
  • definition 31
  • reproductive trauma 31
  • sexual trauma, negative health consequences 154
  • trauma‐related emotions/thoughts/memories, coping 156
• traumatic events
  • cognitive process 11
  • potentially traumatic events (PTE), exposure (impact) 153
• treatment
  • adherence, stigma (influence) 59–60
  • quality, stigma (impact) 59
• treatment as usual (TAU) 167
• trichomoniasis 386
• tricycle antidepressants (TCAs) 464
• tricyclic antidepressants (TCAs) 125
• Truvada (emtricitabine/tenofovir disoproxil fumarate), FDA approval 387
• tuberculosis 438
• type 2 diabetes, patient adherence 218

• Uniform Code of Military Justice (UCMJ), offenses 350
• unintentional patient nonadherence 217
• United Nations Sustainable Development Goals, mortality reduction 90–91
• urinary tract infections (UTIs), prevention 97
• urticaria (hives) 451
• US National Health Interview Survey, smoking/smoking cessation information 226–227
• US Preventive Services Task Force (USPSTF)
  • adult depression screening, recommendation 197–198
  • cancer screening recommendations 75

• vaginal bleeding (miscarriage symptom) 30
• VA Polytrauma Network Site, veteran assessment 188
• ventromedial prefrontal cortex (VMPFC)
  • activation, increase 47
  • activity 52–53
• vertical sleeve gastrectomy, usage 177–178
• violence, threats 421
• viral hepatitis 385
• viral warts 451
• vocational retraining program 276
• voyeuristic disorder 390

• wake time after sleep onset (WASO) 461, 463
• walking
  • depressive symptoms (bidirectional, cyclical association) 145–146
  • Theory of Unpleasant Symptoms (TOUS) 145–146
• walking/depression
  • bidirectional association 144–145
  • relationship 143
• walking impairment 143–144
  • behavioral approaches 148
  • changes, impact 148
  • depressive symptomology, cyclical associations 144
  • depressive symptoms
    • association, possibility 145
    • association, studies 146–147
    • impact, reasons 145
    • longitudinal associations, tested model 147
  • quality of life, association 145
• Walter Reed National Military Medical Center 350
• weight loss
  • behavior, organization 396
  • hypnosis, application 260
  • Look AHEAD study 175
  • medications, FDA approval 175
• weight‐related behaviors, body image (relationship) 4
• Weight Watchers weight‐loss program 174
• Weiss, Steven 358
• well‐being
  • enhancement, prevention (impact) 36
  • promotion, protective factors 37–38
  • tier 1 (three‐tier model) 398–400
• wellness (promotion), reiki (usage) 252
• Wernicke's encephalopathy, chronic drinking (impact) 437
• Western societies, body image concerns (prevalence) 1
• whole medical systems 246
• women
  • anxiety, physician screening (ACOG recommendations) 197–198
  • cancer mortality 73
  • depression, physician screening (ACOG recommendations) 197–198
  • pregnancy, medically assisted reproduction technology (stress) 29
• World Health Organization (WHO)
  • global goals (suicide) 209–210
  • recommendations (suicide) 210–211
• World Report on Disability 278
• worthlessness, feelings 193

• yoga 246, 247, 400
  • styles 250
• youth
  • self‐perception, discussion 40
  • tobacco company targeting 224–225
  • transgender youth, gender dysphoria (psychologist treatment) 351–352

• Zyban (bupropion hydrochloride) 228